The groundbreaking approach of this peptide represents a exciting development in the care of the condition. Unlike existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide993666.review-blogger.com/63643096/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment